Kuano Company
Kuano provides innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.
Investors
.png)
Total Funding:
1000000.0
Headquarters:
London, England, United Kingdom
Funding Status:
Seed
Employee Number:
13
Last Funding Type:
Seed
Technology:
Medical BioTech
Last Funding Date:
2021-07-08
Investors Number:
4.0
Founded Date:
2020-01-01
Industry:
Medical BioTech